Published in Medical Letter on the CDC and FDA, November 7th, 2004
MOBIC has been available to patients in the U.S. since June 2000 for the relief of the signs and symptoms of osteoarthritis. Earlier this year, the U.S. Food and Drug Administration also approved the use of MOBIC for treating the signs and symptoms of rheumatoid arthritis.
Dr. Peter T. Singleton, a clinical professor in Stanford University's department of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA